Cambridge Brain Mets Trial 1

NCT02768337 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

26

Enrollment

OTHER

Sponsor class

Stopped Slow recruitment

Conditions

Lung Cancer
Breast Cancer
Brain Cancer
Advanced Breast Cancer
Advanced Lung Cancer

Interventions

DRUG: Afatinib
RADIATION: 2 Gy targeted radiotherapy
RADIATION: 4 Gy targeted radiotherapy

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]